SCHEMBL2323786

SCHEMBL2323786

CC(=O)OC(C)(C)C.[LiH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28358909 0.97 GAA (0.50)
SCHEMBL28745990 0.97 GAA (0.50)
SCHEMBL28342310 0.97 GAA (0.50)
SCHEMBL26684 0.97
Lithium SCHEMBL30387988 0.93
SCHEMBL6500325 0.93
SCHEMBL28869078 0.93
Ammonia Solution, Strong SCHEMBL6253681 0.93
Hydrochloric Acid SCHEMBL4434111 0.93
Phosphine SCHEMBL11162239 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839128-B1 PROCESS FOR THE PREPARATION OF ETHYL 3S-[[4-[[4-(AMINOIMINOMETHYL)PHENYL]AMINO]-1,4-DIOXOBUTYL]AMINO]-4-PENTYNOATE SEARLE & CO (US) 2000-04-05 EP claimed
EP-0839128-A1 PROCESS FOR THE PREPARATION OF ETHYL 3S-[[4-[[4-(AMINOIMINOMETHYL)PHENYL]AMINO]-1,4-DIOXOBUTYL]AMINO]-4-PENTYNOATE G.D. SEARLE &amp; CO. (US) 1998-05-06 EP claimed
US-5631399-A MULTISTAGE SYNTHESIS USING TRIMETHYLSILYLACETYLENE WITH BUTYLLITHIUM AND FORMYLMORPHOLINE, THEN ACID HYDROLYSIS G. D. SEARLE & CO. (US) 1997-05-20 US claimed
WO-1997003947-A1 PROCESS FOR THE PREPARATION OF ETHYL 3S-[[4-[[4-(AMINOIMINOMETHYL)PHENYL]AMINO]-1,4-DIOXOBUTYL]AMINO]-4-PENTYNOATE G.D. SEARLE & CO. (US) 1997-02-06 WO claimed
US-5536869-A Process for the preparation of ethyl 3S-[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-4-pentynoate G. D. SEARLE & CO. (US) 1996-07-16 US claimed
US-5075448-A Synthesis of swainsonine and analogs thereof MONSANTO COMPANY (US) 1991-12-24 US claimed
CN-112430197-B Synthesis method of 3-oxo-5-hydroxy-6-cyano tert-butyl caproate 江苏阿尔法药业股份有限公司 2023-05-05 CN disclosed
CN-107669669-A novel glucagon receptor antagonist 症变治疗公司 2018-02-09 CN disclosed
CN-101610995-B Glucagon receptor antagonists 症变治疗公司 2017-08-08 CN disclosed
CN-105566265-A Antagonists of the glucagon receptor METABASIS THERAPEUTICS INC 2016-05-11 CN disclosed
US-8785690-B2 Thioamide compound, method for producing thioamide compound, method for producing [(4R,6R)-6-aminoethyl-1,3-dioxan-4-yl]acetate derivative, and method for producing atorvastatin MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) 2014-07-22 US disclosed
CN-101657432-B Dihydro-benzo[B][1,4]diazepin-2-one sulfonamide derivatives HOFFMANN LA ROCHE CH 2013-04-10 CN disclosed
CN-102015658-B Benzimidazole derivatives serving as calcium channel blocker ACTELION PHARMACEUTICALS LTD 2013-03-20 CN disclosed
US-5075448-A Synthesis of swainsonine and analogs thereof MONSANTO COMPANY (US) 1991-12-24 US disclosed
US-5075457-A Synthesis of swainsonine and analogs thereof MONSANTO COMPANY (US) 1991-12-24 US disclosed
US-5023340-A Pyrrolizioines and synthesis thereof MONSANTO COMPANY (US) 1991-06-11 US disclosed
EP-0424349-A1 Synthesis of 1,4-dideoxy-1,4-imino-D-mannitol MONSANTO COMPANY (US) 1991-04-24 EP disclosed
CN-1038099-A Alpha-adrenergic aceptor antagonist SMITHKLINE BECKMAN CORP (US) 1989-12-20 CN disclosed
CN-1038100-A The method for preparing Alpha-Adrenergic receptor antagonist SMITHKLINE BECKMAN CORP (US) 1989-12-20 CN disclosed
EP-0244364-A2 Preparation of olefinic compounds SANDOZ AG (CH) 1987-11-04 EP disclosed